Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
Completed
Esperion Therapeutics
Phase 3
2016-01-21
The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated
versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is
not adequately controlled by their current therapy.
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
Completed
Esperion Therapeutics, Inc.
Phase 3
2016-01-21
The purpose of this study is to see if ETC-1002 (bempedoic acid) is safe and well-tolerated
versus placebo in patients with high cardiovascular risk and elevated LDL cholesterol that is
not adequately controlled by their current therapy.
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Completed
Esperion Therapeutics
Phase 3
2016-11-16
The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe
versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Completed
Esperion Therapeutics, Inc.
Phase 3
2016-11-16
The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe
versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
